Advia Centaur Toxoplasma IgM Assay
by Bayer Corp.
510(k) K010755
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK010755 | Date20 Aug 2001 | StatusActive |
Recalls
No FDA recalls found in the data synced 5 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Bayer Diagnostics Advia Centaur Toxoplasma Igm Assay
- 510(k) Number
- FDA Product Code
- LGD
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.3780
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Advia Centaur Toxoplasma IgM Assay is an Enzyme Linked Immunosorbent Assay (ELISA) designed for the qualitative detection of IgM antibodies to Toxoplasma gondii in human serum or plasma. It aids in the serological diagnosis of acute toxoplasmosis by identifying recent or primary infection through the presence of IgM antibodies, distinguishing it from chronic or latent infection.
This assay is intended for use in clinical microbiology laboratories and is supplied as a reagent kit for in vitro diagnostic use. It is classified as a Class II device under FDA regulations (product code LGD) and has received FDA 510(k) clearance (K010755) as substantially equivalent to a predicate device. The assay is not sterile and is intended for single-use per the manufacturer’s specifications, with storage requirements outlined in the accompanying instructions.
Other devices from Bayer Corp.
Questions
AI-generated answers, 1 Oct 2026
What is the Advia Centaur Toxoplasma IgM Assay used for?
This assay is designed for the qualitative detection of IgM antibodies to *Toxoplasma gondii* in human serum or plasma. It helps distinguish acute or primary toxoplasmosis infections from chronic or latent cases by identifying recent exposure through IgM antibody presence. Clinicians use it in clinical microbiology labs for serological diagnosis.
How is the Advia Centaur Toxoplasma IgM Assay supplied, and is it sterile?
The assay is supplied as a reagent kit intended for in vitro diagnostic use. It is not sterile and is meant for single-use only, as specified by the manufacturer. Each kit contains all necessary components for one test run, ensuring no cross-contamination between samples.
Is this device approved for clinical use, and what regulatory pathway was followed?
Yes, the Advia Centaur Toxoplasma IgM Assay has received FDA 510(k) clearance (K010755) under the Traditional pathway, demonstrating substantial equivalence to a predicate device. It is classified as a Class II device under FDA regulations (product code LGD) and is intended for use in clinical microbiology settings.
What storage requirements apply to the Advia Centaur Toxoplasma IgM Assay?
Storage instructions are detailed in the accompanying instructions provided with the kit. Generally, reagent kits like this are sensitive to temperature and humidity, so they should be stored according to the manufacturer’s guidelines—typically refrigerated (2–8°C) and protected from light until use. Always refer to the included documentation for precise storage conditions.
Can this assay be reused, or is it intended for single-use only?
The Advia Centaur Toxoplasma IgM Assay is explicitly intended for single-use only. Reusing components could compromise test accuracy, introduce contamination, or violate sterility requirements. Each kit is engineered for one diagnostic run, ensuring reliable and reproducible results for patient testing.